PLx Pharma
Latest round
- Series C
Last raised
- Mar 2007
Total raised
- $4.1M
Investors
- 1
About PLx Pharma
Founded in 2002 and based in Texas, US, PLx Pharma Inc. is a pharmaceutical firm that develops Vazalore 325 mg, a liquid-filled aspirin that makes use of a lipid and fatty acid-based targeted release technology called the PLxGuard delivery system which enables selective release of the drug based on pH levels and bile acid contents in the gastrointestinal (GI) tract while reducing the risk of cardiovascular and gastrointestinal complications.
Who invested in PLx Pharma
1 investor across 1 round
See all investors in PLx Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Mar 14, 2007
Amount
$4.1M
Investors
Questions about PLx Pharma
Who invested in PLx Pharma?
PLx Pharma has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has PLx Pharma raised?
PLx Pharma has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did PLx Pharma last raise money?
PLx Pharma's most recent round on record is a Series C, in Mar 2007.
What does PLx Pharma do?
Founded in 2002 and based in Texas, US, PLx Pharma Inc.
Where is PLx Pharma headquartered?
PLx Pharma is headquartered in Houston, US.
Which VCs invest in companies like PLx Pharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at PLx Pharma's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like PLx Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.